应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IMGN ImmunoGen
停牌 02-09 16:00:00 EST
31.23
+0.00
0.00%
最高
31.23
最低
31.23
成交量
0.00
今开
31.23
昨收
31.23
日振幅
0.00%
总市值
87.24亿
流通市值
81.51亿
总股本
2.79亿
成交额
15.18亿
换手率
0.00%
流通股本
2.61亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
制药行业重磅交易:艾伯维以87亿美元收购Cerevel
金十数据 · 2023-12-07
制药行业重磅交易:艾伯维以87亿美元收购Cerevel
独家-艾伯维接近以约 80 亿美元收购药物开发商 Cerevel--消息人士
Reuters · 2023-12-07
独家-艾伯维接近以约 80 亿美元收购药物开发商 Cerevel--消息人士
医药生物行业周报:艾伯维重金收购IMMUNOGEN 建议关注ADC相关创新药企
光大证券股份有... · 2023-12-04
医药生物行业周报:艾伯维重金收购IMMUNOGEN 建议关注ADC相关创新药企
更新版 1-艾伯维将斥资 101 亿美元收购 ImmunoGen,以扩大抗癌药物组合
Reuters · 2023-11-30
更新版 1-艾伯维将斥资 101 亿美元收购 ImmunoGen,以扩大抗癌药物组合
Immunogen Inc盘中异动 大幅拉升5.00%报16.37美元
自选股智能写手 · 2023-11-18
Immunogen Inc盘中异动 大幅拉升5.00%报16.37美元
Immunogen Inc盘中异动 早盘股价大跌5.34%
自选股智能写手 · 2023-11-06
Immunogen Inc盘中异动 早盘股价大跌5.34%
暂无数据
公司概况
公司名称:
ImmunoGen
所属市场:
NASDAQ
上市日期:
--
主营业务:
ImmunoGen, Inc.于1981年在马萨诸塞州组成,专注于基于抗体的抗癌疗法的研发.该公司利用其 专有的抗体药物共轭技术和ADC技术治疗癌症。ADC技术包含一种抗体,ADC一旦绑定目标,该抗体则连接到癌细胞上,结合它的一个强有力的抗癌剂作为“有效载荷”从而杀死癌细胞。ADC是一种治疗癌症的扩展方法,有两种批准治疗方法以及与过去五年相比翻倍的代理数量。
发行价格:
--
{"stockData":{"symbol":"IMGN","market":"US","secType":"STK","nameCN":"ImmunoGen","latestPrice":31.23,"timestamp":1707512400000,"preClose":31.23,"halted":3,"volume":0,"delay":0,"floatShares":261000000,"shares":279354016,"eps":-0.280028,"marketStatus":"停牌","marketStatusCode":7,"change":0,"latestTime":"02-09 16:00:00 EST","open":31.23,"high":31.23,"low":31.23,"amount":1518209038.257658,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.280028,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":627886800000,"adjPreClose":31.23,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/IMGN/tweets","defaultTab":"tweets","newsList":[{"id":"2389601864","title":"制药行业重磅交易:艾伯维以87亿美元收购Cerevel","url":"https://stock-news.laohu8.com/highlight/detail?id=2389601864","media":"金十数据","top":-1,"share":"https://www.laohu8.com/m/news/2389601864?lang=zh_cn&edition=full","pubTime":"2023-12-07 11:52","pubTimestamp":1701921163,"startTime":"0","endTime":"0","summary":"艾伯维称,Cerevel“强大的”神经科学产品线有望为其增加改变精神科和神经系统疾病护理标准的药物。艾伯维表示,两家公司的董事会已批准该交易,预计将于2024年中期完成,但仍须获得Cerevel股东的批准并满足其他成交条件。他还称,艾伯维将利用其深厚的商业能力、国际基础设施以及监管和临床专业知识,为Cerevel的资产组合提供巨大的股东价值和数十亿美元的销售潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120711524683db7833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023120711524683db7833&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2389069686","title":"独家-艾伯维接近以约 80 亿美元收购药物开发商 Cerevel--消息人士","url":"https://stock-news.laohu8.com/highlight/detail?id=2389069686","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2389069686?lang=zh_cn&edition=full","pubTime":"2023-12-07 05:11","pubTimestamp":1701897077,"startTime":"0","endTime":"0","summary":" David Carnevali 路透纽约12月6日 - 熟悉内情的人士周三表示,艾伯维公司 即将以约80亿美元的价格收购Cerevel Therapeutics Holdings Inc ,后者是帕金森等神经系统疾病的药物开发商。消息人士称,艾伯维正在谈判以每股约45美元的价格收购Cerevel公司,该公司得到了私募股权公司贝恩资本的支持。艾伯维和 Cerevel 没有立即回应置评请求。在周三的纽约盘后交易中,Cerevel股价大涨14%至42.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2388786498","title":"医药生物行业周报:艾伯维重金收购IMMUNOGEN 建议关注ADC相关创新药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2388786498","media":"光大证券股份有...","top":-1,"share":"https://www.laohu8.com/m/news/2388786498?lang=zh_cn&edition=full","pubTime":"2023-12-04 00:00","pubTimestamp":1701619200,"startTime":"0","endTime":"0","summary":"本周观点:艾伯维重金收购ImmunoGen,建议关注ADC 相关创新药企2023 年11 月30 日,艾伯维宣布将收购ADC 公司ImmunoGen,获得其FRα ADC新药Elahere 等,此举强化了艾伯维在ADC 领域的布局。2018 年以来,DS-8201 引领了ADC 研发的新一轮热潮,跨国药企纷纷布局。截至目前,ADC 领域的头部生物技术公司几乎都被跨国药企收入囊中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204152523822b81ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231204152523822b81ee&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2387449553","title":"更新版 1-艾伯维将斥资 101 亿美元收购 ImmunoGen,以扩大抗癌药物组合","url":"https://stock-news.laohu8.com/highlight/detail?id=2387449553","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2387449553?lang=zh_cn&edition=full","pubTime":"2023-11-30 20:41","pubTimestamp":1701348086,"startTime":"0","endTime":"0","summary":"(全文增加细节) 路透11月30日 - 艾伯维 周四表示,它将以101亿美元的价格收购制药商ImmunoGen ,从而提升其在癌症治疗市场的地位。这家制药商将为每股ImmunoGen股票支付31.26美元现金,比上次收盘价溢价94.6%。 艾伯维表示,这项交易预计将于2024年中期完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2384361059","title":"Immunogen Inc盘中异动 大幅拉升5.00%报16.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2384361059","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2384361059?lang=zh_cn&edition=full","pubTime":"2023-11-18 01:43","pubTimestamp":1700242982,"startTime":"0","endTime":"0","summary":"北京时间2023年11月18日01时43分,Immunogen Inc股票出现波动,股价急速拉升5.00%。截至发稿,该股报16.37美元/股,成交量270.734万股,换手率1.02%,振幅4.84%。Immunogen Inc股票所在的生物技术行业中,整体涨幅为1.41%。Immunogen Inc公司简介:Immunogen Inc 是一家来自美国的临床阶段生物技术公司,专注于抗体药物偶联物或 ADC 技术,该技术使用固定在肿瘤细胞上发现的靶标(其抗原)上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118014302839d90ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231118014302839d90ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2381110842","title":"Immunogen Inc盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2381110842","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2381110842?lang=zh_cn&edition=full","pubTime":"2023-11-06 22:31","pubTimestamp":1699281067,"startTime":"0","endTime":"0","summary":"北京时间2023年11月06日22时31分,Immunogen Inc股票出现波动,股价大幅下挫5.34%。Immunogen Inc股票所在的生物技术行业中,整体涨幅为1.22%。Immunogen Inc公司简介:Immunogen Inc 是一家来自美国的临床阶段生物技术公司,专注于抗体药物偶联物或 ADC 技术,该技术使用固定在肿瘤细胞上发现的靶标(其抗原)上的抗体来递送特定的抗癌剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106223107847606e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231106223107847606e8&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunogen.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0.0673},{"period":"6month","weight":0.9171},{"period":"1year","weight":1.3517},{"period":"ytd","weight":0.0533}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunoGen, Inc.于1981年在马萨诸塞州组成,专注于基于抗体的抗癌疗法的研发.该公司利用其 专有的抗体药物共轭技术和ADC技术治疗癌症。ADC技术包含一种抗体,ADC一旦绑定目标,该抗体则连接到癌细胞上,结合它的一个强有力的抗癌剂作为“有效载荷”从而杀死癌细胞。ADC是一种治疗癌症的扩展方法,有两种批准治疗方法以及与过去五年相比翻倍的代理数量。","yearOnYearQuotes":[{"month":1,"riseRate":0.485714,"avgChangeRate":0.058335},{"month":2,"riseRate":0.4,"avgChangeRate":0.019916},{"month":3,"riseRate":0.294118,"avgChangeRate":-0.02625},{"month":4,"riseRate":0.441176,"avgChangeRate":0.040179},{"month":5,"riseRate":0.558824,"avgChangeRate":0.055439},{"month":6,"riseRate":0.5,"avgChangeRate":0.057736},{"month":7,"riseRate":0.441176,"avgChangeRate":0.001299},{"month":8,"riseRate":0.470588,"avgChangeRate":0.016012},{"month":9,"riseRate":0.441176,"avgChangeRate":0.012768},{"month":10,"riseRate":0.529412,"avgChangeRate":0.011371},{"month":11,"riseRate":0.588235,"avgChangeRate":0.099293},{"month":12,"riseRate":0.457143,"avgChangeRate":-0.000761}],"exchange":"NASDAQ","name":"ImmunoGen","nameEN":"Immunogen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunoGen,IMGN,ImmunoGen股票,ImmunoGen股票老虎,ImmunoGen股票老虎国际,ImmunoGen行情,ImmunoGen股票行情,ImmunoGen股价,ImmunoGen股市,ImmunoGen股票价格,ImmunoGen股票交易,ImmunoGen股票购买,ImmunoGen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunoGen(IMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunoGen(IMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}